Stay Informed: Transforming Radiology with Structured Reporting and Data-Driven Approaches

Dive into our activities, projects, and product updates. Catch on the latest industry news and learn who we are as a company and as a team.

We Go Pink for Breast Cancer Awareness

October 1 marks the beginning of Breast Cancer Awareness Month, and the team of Mint Ladies from our Heidelberg office is wearing pink today.

We wear pink to raise awareness. About 1 in 8 women will get breast cancer during her life. It can be any one of us, a family member, a friend, or a colleague. Let us remind one another to take care of ourselves and do regular checkups. By the way, in rare cases, breast cancer can occur in men too, so be aware and react if needed! 

We wear pink to support and empower all those affected by breast cancer and all the hardship that comes along with it. You are strong, you are beautiful, you are resilient, and you are not alone! 

We wear pink to celebrate all the amazing healthcare providers, scientists, engineers, software developers, social workers, volunteers, and advocates who contribute in so many different ways to the global fight against this disease. You rock!

Our way to make an impact as a company is to support cancer research by fostering data-driven radiology and providing clinicians with the path to imaging data far beyond what the eye can see. 

 

Related Resources

Related Resources

High-quality annotated data in clinical routine

The desire to standardize reporting and to get even more out of their oncological images led to the partnership of the Noordwest Ziekenhuisgroep in…

Raising our awareness in pediatric cancer

The terms rare, uncommon, infrequent are commonly used to describe the occurrence of cancer in children –  from a prevalence perspective, “only”…

MDR certification: Another affirmation of the quality and safety of our software solution

We are pleased to announce that we, as a medical software developer, have received the MDR certificate for the manufacture of class IIa and IIb…